Gráfico simples
Agenda avançada
Descrição Tema Obesity & Cardiometabolic ETF
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.| Assets class size | Multi-Cap |
|---|---|
| Country | USA |
| Country ISO | US |
| Focus | Health Care |
| Issuer | Dawn Global Topco Ltd. |
| Region specific | Broad |
| Segment | Equity: Global Pharma, Biotech & Life Sciences |
| Strategy | Active |
| Валюта | usd |
| Годовая доходность | 27 |
| Дата основания | Nov 21. 2023 |
| Индекс | ACTIVE - No Index |
| Количество компаний | 10 |
| Комиссия | 0.75 |
| Полное наименование | Tema Obesity & Cardiometabolic ETF |
| Регион | Global |
| Сайт | link |
| Средний P/E | 16.57 |
| Тип актива | Equity |
| Alteração de preço por dia: | 0% (29.98) |
|---|---|
| Alteração de preço por semana: | -0.7613% (30.21) |
| Alteração de preço por mês: | -2.47% (30.74) |
| Alteração de preço em 3 meses: | +1.52% (29.53) |
| Mudança de preço em seis meses: | -11.46% (33.86) |
| Mudança de preço desde o início do ano: | +1.15% (29.64) |
Pague pela sua assinatura
Mais funcionalidades e dados para análise de empresas e portfólio estão disponíveis por assinatura
| Nome | Indústria | Compartilhar, % | P/BV | P/S | P/E | EV/Ebitda | Rendimento de dividendos |
|---|---|---|---|---|---|---|---|
 Amgen |
Healthcare | 7.08994 | 24.53 | 5.42 | 22.76 | 26.16 | 2.92 |
 Eli Lilly and Company |
Healthcare | 5.52241 | 47.43 | 15.1 | 98.32 | 43.16 | 0.5892 |
 Alnylam Pharmaceuticals, Inc. |
Healthcare | 5.30214 | -108.14 | 13.05 | 0 | -112.79 | 0 |
 Vertex |
Healthcare | 4.44564 | 6 | 10.73 | 29.17 | 24.42 | 0 |
 BridgeBio Pharma, Inc. |
Healthcare | 4.07181 | -5.09 | 734.78 | 0 | -14.27 | 0 |
 Chugai Pharmaceutical Co., Ltd. |
Healthcare | 3.73691 | 5.41 | 7.92 | 27.04 | 18.68 | 2.06 |
 Ultragenyx Pharmaceutical Inc. |
Healthcare | 3.46775 | 12.68 | 8.04 | 0 | -6.43 | 0 |
 Cytokinetics, Incorporated |
Healthcare | 3.31875 | -11.14 | 571.71 | 0 | -10.22 | 0 |
 AstraZeneca PLC |
Healthcare | 3.14097 | 2.49 | 1.88 | 14.45 | 7.38 | 1.98 |
| 40.1 | -2.87 | 152.07 | 21.3 | -2.66 | 0.84 |
